Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression

GLIA

Volumn 61, Issue 9, 2013, Pages 1471-1487

  Plemel, Jason R ^a,b   Manesh, Sohrab B ^a   Sparling, Joseph S ^a,b   Tetzlaff, Wolfram ^a,b  

^a INTERNATIONAL COLLABORATION ON REPAIR DISCOVERIES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Myelin; Oligodendrocyte; Oligodendrocyte precursor cell; Remyelination; Transcription factor

Indexed keywords

MYELIN; MYELIN BASIC PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BRAIN; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME SUBSTRATE; IMMUNOCYTOCHEMISTRY; INHIBITION KINETICS; LIVER MEMBRANE; MICROENVIRONMENT; NONHUMAN; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMYELINIZATION; RNA PURIFICATION; STEM CELL;

EID: 84880818990     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22535     Document Type: Article

References (120)

1. Abe Y, Yamamoto T, Sugiyama Y, Watanabe T, Saito N, Kayama H, Kumagai T. 1999. Apoptotic cells associated with Wallerian degeneration after experimental spinal cord injury: A possible mechanism of oligodendroglial death. J Neurotrauma 16:945-952.
2. Aguirre AA, Chittajallu R, Belachew S, Gallo V. 2004. NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus. J Cell Biol 165:575-589.
3. Azim K, Butt AM. 2011. GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 59:540-553.
4. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, Trapp BD, Bebo BF Jr, Rao MS, Sherman LS. 2005. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11:966-972.
5. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, Franklin RJ, Altmann F, Lubec G, Kotter MR. 2009. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132(Part 2):465-481.
6. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. 1989. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 24:548-557.
7. Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P. 2003. Remyelinated lesions in multiple sclerosis: Magnetic resonance image appearance. Arch Neurol 60:1073-1081.
8. Barres BA, Raff MC. 1993. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature 361:258-260.
9. Barres BA, Raff MC. 1999. Axonal control of oligodendrocyte development. J Cell Biol 147:1123-1128.
10. Basso DM, Beattie MS, Bresnahan JC. 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244-256.
11. Baumann N, Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927.
12. Beattie MS, Bresnahan JC, Komon J, Tovar CA, Van Meter M, Anderson DK, Faden AI, Hsu CY, Noble LJ, Salzman S, Young W. 1997. Endogenous repair after spinal cord contusion injuries in the rat. Exp Neurol 148:453-463.
13. Becerra JL, Puckett WR, Hiester ED, Quencer RM, Marcillo AE, Post MJ, Bunge RP. 1995. MR-pathologic comparisons of wallerian degeneration in spinal cord injury. AJNR Am J Neuroradiol 16:125-133.
14. Belachew S, Chittajallu R, Aguirre AA, Yuan X, Kirby M, Anderson S, Gallo V. 2003. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 161:169-186.
15. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. 1990. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
16. Blight AR. 1985. Delayed demyelination and macrophage invasion: A candidate for secondary cell damage in spinal cord injury. Cent Nerv Syst Trauma 2:299-315.
17. Buss A, Brook GA, Kakulas B, Martin D, Franzen R, Schoenen J, Noth J, Schmitt AB. 2004. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain 127:34-44.
18. Buss A, Pech K, Merkler D, Kakulas BA, Martin D, Schoenen J, Noth J, Schwab ME, Brook GA. 2005. Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord. Brain 128:356-364.
19. Buss A, Schwab ME. 2003. Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia 42:424-432.
20. Casaccia-Bonnefil P, Hardy RJ, Teng KK, Levine JM, Koff A, Chao MV. 1999. Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 126:4027-4037.
21. Casha S, Yu WR, Fehlings MG. 2001. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103:203-218.
22. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. 2000. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404-6412.
23. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
24. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, Zalc B, Lubetzki C. 2000. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci USA 97:7585-7590.
25. Chen XS, Zhang YH, Cai QY, Yao ZX. 2012. ID2: A negative transcription factor regulating oligodendroglia differentiation. J Neurosci Res 90:925-932.
26. Chen Y, Wu H, Wang S, Koito H, Li J, Ye F, Hoang J, Escobar SS, Gow A, Arnett HA, Trapp BD, Karandikar NJ, Hsieh J, Lu QR. 2009. The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat Neurosci 12:1398-1406.
27. Cheng X, Wang Y, He Q, Qiu M, Whittemore SR, Cao Q. 2007. Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells 25:3204-3214.
28. Chojnacki A, Weiss S. 2004. Isolation of a novel platelet-derived growth factor-responsive precursor from the embryonic ventral forebrain. J Neurosci 24:10888-10899.
29. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. 1997. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3:73-76.
30. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA. 2010. Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597-611.
31. Dugas JC, Ibrahim A, Barres BA. 2007. A crucial role for p57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci 27:6185-6196.
32. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. 2006. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26:10967-10983.
33. Duncan ID, Kondo Y, Zhang SC. 2011. The myelin mutants as models to study myelin repair in the leukodystrophies. Neurotherapeutics 8:607-624.
34. Durand B, Raff M. 2000. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 22:64-71.
35. Eftekharpour E, Karimi-Abdolrezaee S, Fehlings MG. 2008. Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 24(3-4):E19.
36. Emery B. 2010. Regulation of oligodendrocyte differentiation and myelination. Science 330:779-782.
37. Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, Ibrahim A, Ligon KL, Rowitch DH, Barres BA. 2009. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138:172-185.
38. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH. 2009. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23:1571-1585.
39. Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH. 2011a. Myelin regeneration: A recapitulation of development? Annu Rev Neurosci 34:21-43.
40. Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ, Huang EJ, Nusse R, Franklin RJ, Rowitch DH. 2011b. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14:1009-1016.
41. Feigenson K, Reid M, See J, Crenshaw EB III, Grinspan JB. 2009. Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol Cell Neurosci 42:255-265.
42. Fewou SN, Ramakrishnan H, Bussow H, Gieselmann V, Eckhardt M. 2007. Down-regulation of polysialic acid is required for efficient myelin formation. J Biol Chem 282:16700-16711.
43. Filbin MT. 2003. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 4:703-713.
44. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
45. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9:839-855.
46. George R, Griffin JW. 1994. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: The dorsal radiculotomy model. Exp Neurol 129:225-236.
47. Ghosh A, Manrique-Hoyos N, Voigt A, Schulz JB, Kreutzfeldt M, Merkler D, Simons M. 2011. Targeted ablation of oligodendrocytes triggers axonal damage. PLoS One 6:e22735.
48. Gilson J, Blakemore WF. 1993. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 19:173-181.
49. Gledhill RF, Harrison BM, McDonald WI. 1973. Demyelination and remyelination after acute spinal cord compression. Exp Neurol 38:472-487.
50. Gokhan S, Marin-Husstege M, Yung SY, Fontanez D, Casaccia-Bonnefil P, Mehler MF. 2005. Combinatorial profiles of oligodendrocyte-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression. J Neurosci 25:8311-8321.
51. Griffin JW, George R, Lobato C, Tyor WR, Yan LC, Glass JD. 1992. Macrophage responses and myelin clearance during Wallerian degeneration: Relevance to immune-mediated demyelination. J Neuroimmunol 40(2-3):153-165.
52. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
53. Hampton DW, Innes N, Merkler D, Zhao C, Franklin RJ, Chandran S. 2012. Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency. Am J Pathol 180:1897-1905.
54. Harrison BM, McDonald WI. 1977. Remyelination after transient experimental compression of the spinal cord. Ann Neurol 1:542-551.
55. He Y, Dupree J, Wang J, Sandoval J, Li J, Liu H, Shi Y, Nave KA, Casaccia-Bonnefil P. 2007. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55:217-230.
56. Hinks GL, Franklin RJ. 2000. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol Cell Neurosci 16:542-556.
57. Huang JK, Jarjour AA, Nait Oumesmar B, Kerninon C, Williams A, Krezel W, Kagechika H, Bauer J, Zhao C, Evercooren AB, Chambon P, Ffrench-Constant C, Franklin RJ. 2011. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 14:45-53.
58. Irvine KA, Blakemore WF. 2006. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 175(1-2):69-76.
59. Irvine KA, Blakemore WF. 2008. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131(Part 6):1464-1477.
60. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Schut D, Fehlings MG. 2010. S ynergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 30:1657-1676.
61. Kee N, Sivalingam S, Boonstra R, Wojtowicz JM. 2002. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods 115:97-105.
62. Kondo T, Raff M. 2000. The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J 19:1998-2007.
63. Kotter MR, Li WW, Zhao C, Franklin RJ. 2006. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26:328-332.
64. Kotter MR, Stadelmann C, Hartung HP. 2011. Enhancing remyelination in disease-Can we wrap it up? Brain 134(Part 7):1882-1900.
65. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131(Part 7):1749-1758.
66. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
67. Lasiene J, Shupe L, Perlmutter S, Horner P. 2008. No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. J Neurosci 28:3887-3896.
68. Li GL, Farooque M, Holtz A, Olsson Y. 1999. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord. Acta Neuropathol 98:473-480.
69. Liu BP, Cafferty WB, Budel SO, Strittmatter SM. 2006. Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci 361:1593-1610.
70. Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW, Dong HX, Wu YJ, Fan GS, Jacquin MF, Hsu CY, Choi DW. 1997. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17:5395-5406.
71. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
72. Locatelli G, Wortge S, Buch T, Ingold B, Frommer F, Sobottka B, Kruger M, Karram K, Buhlmann C, Bechmann I, Heppner FL, Waisman A, Becher B. 2012. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat Neurosci 15:543-550.
73. Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA. 1997. Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells. J Neurosci 17:4112-4120.
74. Marin-Husstege M, He Y, Li J, Kondo T, Sablitzky F, Casaccia-Bonnefil P. 2006. Multiple roles of Id4 in developmental myelination: Predicted outcomes and unexpected findings. Glia 54:285-296.
75. McTigue DM, Tripathi RB. 2008. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 107:1-19.
76. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, Wong WM, Wang L, Su H, Chu TH, Guo J, Zhang W, So KF, Pepinsky B, Shao Z, Graff C, Garber E, Jung V, Wu EX, Wu W. 2007. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 13:1228-1233.
77. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. 2004. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221-228.
78. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. 2005. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8:745-751.
79. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B. 2009. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 65:304-315.
80. Miklossy J, Van der Loos H. 1991. The long-distance effects of brain lesions: Visualization of myelinated pathways in the human brain using polarizing and fluorescence microscopy. J Neuropathol Exp Neurol 50:1-15.
81. Nave KA. 2010a. Myelination and support of axonal integrity by glia. Nature 468:244-252.
82. Nave KA. 2010b. Myelination and the trophic support of long axons. Nat Rev Neurosci 11:275-283.
83. Nave KA, Trapp BD. 2008. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31:535-561.
84. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. 1988. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560-562.
85. Norton WT, Poduslo SE. 1973. Myelination in rat brain: Method of myelin isolation. J Neurochem 21:749-757.
86. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H. 2006. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12:829-834.
87. Ousman SS, David S. 2000. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30:92-104.
88. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129(Part 12):3165-3172.
89. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
90. Plemel JR, Chojnacki A, Sparling JS, Liu J, Plunet W, Duncan GJ, Park SE, Weiss S, Tetzlaff W. 2011. Platelet-derived growth factor-responsive neural precursors give rise to myelinating oligodendrocytes after transplantation into the spinal cords of contused rats and dysmyelinated mice. Glia 59:1891-1910.
91. Pohl HB, Porcheri C, Mueggler T, Bachmann LC, Martino G, Riethmacher D, Franklin RJ, Rudin M, Suter U. 2011. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci 31:1069-1080.
92. Powers BE, Lasiene J, Plemel JR, Shupe L, Perlmutter SI, Tetzlaff W, Horner PJ. 2012. Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats. J Neurosci 32:5120-5125.
93. Prineas JW, Connell F. 1979. Remyelination in multiple sclerosis. Ann Neurol 5:22-31.
94. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD. 1988. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333:562-565.
95. Robinson S, Miller RH. 1999. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev Biol 216:359-368.
96. Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJ. 2012. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10:96-103.
97. Sabo JK, Aumann TD, Merlo D, Kilpatrick TJ, Cate HS. 2011. Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions. J Neurosci 31:4504-4510.
98. Samanta J, Kessler JA. 2004. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131:4131-4142.
99. Schwab ME. 2004. Nogo and axon regeneration. Curr Opin Neurobiol 14:118-124.
100. Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, Casaccia-Bonnefil P. 2008. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 11:1024-1034.
101. Shields SA, Gilson JM, Blakemore WF, Franklin RJ. 1999. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 28:77-83.
102. Sim FJ, Zhao C, Penderis J, Franklin RJ. 2002. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22:2451-2459.
103. Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T. 2010. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci USA 107:11555-11560.
104. Smith PM, Jeffery ND. 2006. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol 16:99-109.
105. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, Wegner M. 2002. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 16:165-170.
106. Sun XH, Copeland NG, Jenkins NA, Baltimore D. 1991. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol 11:5603-5611.
107. Syed YA, Baer AS, Lubec G, Hoeger H, Widhalm G, Kotter MR. 2008. Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins. Neurosurg Focus 24(3-4):E5.
108. Temple S, Raff MC. 1986. Clonal analysis of oligodendrocyte development in culture: Evidence for a developmental clock that counts cell divisions. Cell 44:773-779.
109. Tokumoto YM, Apperly JA, Gao FB, Raff MC. 2002. Posttranscriptional regulation of p18 and p27 Cdk inhibitor proteins and the timing of oligodendrocyte differentiation. Dev Biol 245:224-234.
110. Totoiu MO, Keirstead HS. 2005. Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 486:373-383.
111. Traka M, Arasi K, Avila RL, Podojil JR, Christakos A, Miller SD, Soliven B, Popko B. 2010. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain 133:3017-3029.
112. Trapp BD, Nave KA. 2008. Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31:247-269.
113. Tripathi R, McTigue DM. 2007. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 55:698-711.
114. Wang S, Sdrulla A, Johnson JE, Yokota Y, Barres BA. 2001. A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron 29:603-614.
115. Watkins TA, Emery B, Mulinyawe S, Barres BA. 2008. Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 60:555-569.
116. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601-609.
117. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H, Hsieh J, Bassel-Duby R, Olson EN, Lu QR. 2009. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 12:829-838.
118. Yiu G, He Z. 2006. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7:617-627.
119. Yokota Y. 2001. Id and development. Oncogene 20:8290-8298.
120. Zhao C, Li WW, Franklin RJ. 2006. Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination. Neurobiol Aging 27:1298-1307.